PADAGIS NALOXONE
Summary of public USPTO data
- Owner
- PADAGIS US LLC
- Status
- Live/Registered
- Serial number
- 98860507
- Registration number
- 8287706
- Filing date
- 2024-11-19
- Registration date
- 2026-06-02
- International classes
- 5, 20, 35, 44
Goods and services
Class 5
- Medicinal pharmaceutical preparations used as a narcotic antagonist for the treatment of opioid overdose
- pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists for the treatment of opioid overdose
- pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose
- intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all being drug delivery agents in nasal spray form that facilitate the delivery of pre-filled pharmaceuticals preparations, namely, opioid antagonists and narcotic antagonists and pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose
- nasal spray preparations
- Medical kits, namely opioid overdose response kits comprising pharmaceutical preparations for use in treatment of opiate, opioid or narcotic overdose and also including carrying cases, training kits containing nasal spray bottles sold empty, and storage cabinets for medical kits of intranasal drug delivery devices
Class 20
- Medicine cabinets
Class 35
- Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose
- online retail pharmacy services
Class 44
- Providing medical and health information services
- providing a website for patients, medical professionals, and pharmacists featuring medical information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips
- providing a website featuring pharmaceutical drug medical information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists